Dynamin-3 (DNM3) is a member of the dynamin family of large GTPases that play critical roles in synaptic vesicle recycling and membrane trafficking in neurons. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Dynamin-3 is a ~870-amino acid GTPase protein encoded by the DNM3 gene. It belongs to the dynamin family of mechanochemical GTPases that catalyze membrane scission during vesicle formation. Unlike Dynamin-1 (primarily presynaptic) and Dynamin-2 (ubiquitous), Dynamin-3 is enriched in the brain with specific expression in postsynaptic structures, particularly dendritic spines and excitatory synapses.
Dynamin-3 plays essential roles in synaptic plasticity, neurotransmitter release, and neuronal signaling. Research has implicated DNM3 variants in neurodegenerative diseases, making it a potential therapeutic target.
Dynamin-3 shares the canonical domain architecture with other dynamin family members:
- GTPase Domain: N-terminal domain (~300 aa) that binds and hydrolyzes GTP, providing the mechanical force for membrane scission
- Middle Domain: Central region involved in self-assembly and dimerization
- Pleckstrin Homology (PH) Domain: Binds phosphatidylinositol (4,5)-bisphosphate (PIP2) at the plasma membrane
- GTPase Effector Domain (GED): C-terminal region that regulates GTPase activity and interacts with actin
The protein forms dimers and higher-order oligomers that assemble around neck geometries of budding vesicles, undergoing conformational changes during the scission reaction.
Dynamin-3 is primarily localized to postsynaptic compartments, where it participates in:
- Synaptic Vesicle Recycling: Facilitates endocytosis of synaptic vesicles at the presynaptic terminal
- Dendritic Spine Morphogenesis: Regulates the formation and maintenance of dendritic spines, which are critical for excitatory synaptic transmission
- Postsynaptic Receptor Trafficking: Involved in the endocytosis and recycling of glutamate receptors, particularly AMPA receptors
- Actin Cytoskeleton Dynamics: Interacts with the actin cytoskeleton to regulate spine structure and plasticity
Dynamin-3 interacts with several neuronal signaling pathways:
- Synaptic Activity-Dependent Signaling: Regulated by calcium influx and synaptic activity
- BDNF Signaling: Involved in brain-derived neurotrophic factor-mediated synaptic plasticity
- NMDA Receptor Signaling: Couples NMDA receptor activity to endocytic trafficking
Research suggests Dynamin-3 may be implicated in Alzheimer's disease pathogenesis:
- Synaptic dysfunction is an early hallmark of AD, and DNM3 expression is altered in AD brain tissue
- Dynamin-3-mediated endocytosis is involved in amyloid-beta toxicity and synaptic clearance mechanisms
- The protein may play a role in the trafficking of amyloid precursor protein (APP) and its processing products
In Parkinson's disease, Dynamin-3 may contribute to:
- Dopaminergic neuron survival and synaptic maintenance
- Alpha-synuclein clearance pathways
- Mitochondrial dynamics and quality control
Dynamin-3 has been implicated in ALS through:
- Synaptic dysfunction in motor neurons
- Endocytic trafficking deficits
- Interactions with ALS-related proteins such as TDP-43
The DNM3 gene is located on chromosome 1p31.3. Studies have identified:
- Single nucleotide polymorphisms (SNPs) in DNM3 associated with risk for neurodegenerative diseases
- Expression quantitative trait loci (eQTLs) affecting DNM3 expression in brain tissue
- Potential protective variants requiring further validation
Dynamin-3 represents a potential therapeutic target for neurodegenerative diseases:
- Modulation of Synaptic Plasticity: Small molecules targeting dynamin GTPase activity could normalize synaptic function
- Gene Therapy: Viral vector-mediated delivery of wild-type DNM3 to restore function
- Protein-Protein Interaction Inhibitors: Disruption of pathogenic protein interactions
- Dynamin-3 knockout mice show deficits in synaptic transmission and learning/memory
- DNM3 expression is downregulated in Alzheimer's disease brain
- Dynamin-3 localizes to dendritic spines and regulates AMPA receptor trafficking
- The protein interacts with actin cytoskeleton through cortactin and cofilin